Advertisement

Cancer Immunology, Immunotherapy

, Volume 40, Issue 2, pp 109–114 | Cite as

Anti-CD30 immunotoxins with native and recombinant dianthin 30

  • Andrea Bolognesi
  • Pier Luigi Tazzari
  • Guiseppe Legname
  • Fabiola Olivieri
  • Daniela Modena
  • Roberto Conte
  • Fiorenzo Stirpe
Original Article Immunotoxin, Dianthin, Ribosome-Inactivating Protein, Hodgkin's Lymphoma

Abstract

Immunotoxins were prepared with a Ber-H2 (anti-CD30) monoclonal antibody and native or recombinant dianthin 30, a ribosome-inactivating protein fromDianthus caryophyllus (carnation). Both immunotoxins selectively inhibited protein synthesis by CD30+ cell lines D430B (lymphoblastoid, infected with Epstein-Barr virus). L428 and L540 (both from Hodgkin's lymphoma). IC50 values (concentrations, as dianthin, causing 50% inhibition) ranged from 324 pM to 479 pM (immunotoxin with native dianthin 30) or from 45 pM to 182 pM (immunotoxin with recombinant dianthin 30). The effect of either immunotoxin on protein synthesis by the CD30 cell line K562 (from a chronic myeloid leukaemia) was not different from that of free dianthin (IC50 higher than nM).

Key words

Immunotoxin Dianthin Ribosome-inactivating protein Hodgkin's lymphoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barbieri L, Battelli MG, Stirpe F (1993) Ribosome-inactivating proteins from plants. Biochim Biophys Acta 1154:327PubMedGoogle Scholar
  2. 2.
    Endo Y (1988) Mechanism of action of ricin and related toxins on the inactivation of ribosomes: In Frankel AE (ed) Immunotoxins. Kluwer, Boston, p 75Google Scholar
  3. 3.
    Ramakrishnan S, Fryxell D, Mohanraj D, Olson M, Li BY (1992) Cytotoxic conjugates containing translational inhibitory proteins. Annu Rev Pharmacol Toxicol 32:579PubMedGoogle Scholar
  4. 4.
    Vitetta ES, Thorpe PE, Uhr JW (1993) Immunotoxins: magic bullets or misguided missiles? Immunol Today 14:252PubMedGoogle Scholar
  5. 5.
    Pastan I, Chaudhary V, FitzGerald D (1992) Recombinant toxins as novel therapeutic agents. Annu Rev Biochem 61:331PubMedGoogle Scholar
  6. 6.
    Legname G, Bellosta P, Gromo G, Modena D, Keen JN, Roberts LM, Lord JM (1991) Nucleotide sequence of cDNA coding for dianthin-30, a ribosome-inactivating protein fromDianthus caryophyllus. Biochim Biophys Acta 1090:119PubMedGoogle Scholar
  7. 7.
    Legname G, Gromo G, Lord JM, Monzini N, Lord JM (1993) Expression and activity of pre-dianthin 30 and dianthin 30. Biochem Biophys Res Commun 192:1230PubMedGoogle Scholar
  8. 8.
    Stirpe F, Williams DG, Onyon LJ, Legg RF, Stevens WA (1981) Dianthins, ribosome-damaging proteins with anti-viral properties fromDianthus caryophyllus L. (carnation). Biochem J 195:399PubMedGoogle Scholar
  9. 9.
    Falini BA, Bolognesi A, Flenghi L, Tazzari PL, Broe MK, Stein H, Dürkop H, Aversa F, Corneli P, Pizzolo G, Barbabietola G, Sabattini E, Pileri S, Martelli MF, Stirpe F (1992) Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin. Lancet 339:1195PubMedGoogle Scholar
  10. 10.
    Barbieri L, Stoppa C, Bolognesi A (1987) Large scale chromatographic purification of ribosome-inactivating proteins. J Chromatogr 408:235Google Scholar
  11. 11.
    Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NYGoogle Scholar
  12. 12.
    Studier FW, Rosemberg AH, Dunn JJ, Dubendorff JW (1990) Methods Enzymol 185:61Google Scholar
  13. 13.
    Schwarting R, Gerde J, Dürkop H, Falini B, Pileri S, Stein H (1989) Ber-H2: a new anti-K1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74:1678PubMedGoogle Scholar
  14. 14.
    Bolognesi A, Barbieri L, Carnicelli D, Abbondanza A, Cenini P, Falasca AI, Dinota A, Stirpe F (1989) Purification and properties of a new ribosome-inactivating protein with RNAN-glycosidase activity suitable for immunotoxin preparation from the seeds ofMomordica cochinchinensis. Biochim Biophys Acta 993:287PubMedGoogle Scholar
  15. 15.
    Poccia F, Piselli P, Di Cesare F, Bach S, Colizzi V, Mattei M, Bolognesi A, Stirpe F (1992) Recognition and killing of tumour expressing heat shock protein 65 kD with immunotoxins containing saporin. Br J Cancer 66:427PubMedGoogle Scholar
  16. 16.
    Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70PubMedGoogle Scholar
  17. 17.
    Bolognesi A, Tazzari PL, Tassi C, Gromo G, Gobbi M, Stirpe F (1992) Comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies. Clin Exp Immunol 89:341PubMedGoogle Scholar
  18. 18.
    Schaadt M, Diehl V, Stein H, Fonatsch H, Kirchner H (1980) Two neoplastic cell lines with unique features derived from Hodgkin's disease. Int J Cancer 26:723PubMedGoogle Scholar
  19. 19.
    Engert A, Burrows E, Jung W, Tazzari PL, Stein H, Pfreundschuh M, Diehl V, Thorpe P (1990) Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagent for the treatment of Hodgkin's disease. Cancer Res 50:84PubMedGoogle Scholar
  20. 20.
    Ferreras JM, Barbieri L, Girbés T, Battelli MG, Rojo MA, Arias FJ, Rocher MA, Soriano F, Mendez E, Stirpe F (1993) Distribution and properties of major ribosome-inactivating proteins (28 S rRNAN-glycosidases) of the plantSaponaria officinalis L. (Caryophyllaceae). Biochim Biophys Acta 1216:31PubMedGoogle Scholar
  21. 21.
    Tazzari PL, Bolognesi A, De Totero D, Falini B, Lemoli RM, Soria MR, Pileri S, Gobbi M, Stein H, Flenghi L, Martelli MF, Stirpe F (1992) Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma. In vitro evaluation. Br J Haematol 81:203PubMedGoogle Scholar
  22. 22.
    Benatti L, Nitti G, Solinas M, Valsasina B, Vitale A, Ceriotti A, Soria MR (1991) A saporin-6 cDNA containing a precursor sequence coding for a carboxyl-terminal extension. FEBS Lett 291:285PubMedGoogle Scholar
  23. 23.
    Wawrzinczak EJ, Cumber AJ, Henry RV, Parnell GD, Westwood JH (1992) Structural factors influencing the pharmacokinetics and stability of immunotoxins. Biochem Soc Trans 20:738PubMedGoogle Scholar
  24. 24.
    Duke-Cohan JS, Morimoto C, Schlossman SF (1993) Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29. Transplantation 56:1188PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Andrea Bolognesi
    • 1
  • Pier Luigi Tazzari
    • 2
  • Guiseppe Legname
    • 3
  • Fabiola Olivieri
    • 1
  • Daniela Modena
    • 3
  • Roberto Conte
    • 2
  • Fiorenzo Stirpe
    • 1
  1. 1.Dipartimento di Patologia sperimentale dell'Università di BolognaBolognaItaly
  2. 2.Servizio di Immunoematologia e transfusionalePoliclinico S. OrsolaBolognaItaly
  3. 3.Centro Ricerche ItalfarmacoCinisello Balsamo MIItaly

Personalised recommendations